
Figure 1. QRFP26-induced concentration-dependent stimulation of intracellular calcium mobilization in CHO-K1/GPR103/Gα15 cells. The cells were loaded with Calcium-4 prior to being stimulated with agonist QRFP26 (26RFa). The intracellular calcium change was measured by FLIPR. The relative fluorescent units (RFU) were plotted against the log of the cumulative doses of 26RFa (Mean ± SEM, n = 3). The EC50 of 26RFa on this cell was 0.16 μM.
Notes:
EC50 value is calculated with four parameter logistic equation:
Y=Bottom + (Top-Bottom) / (1+10^((LogEC50-X)*Hill Slope))
X is the logarithm of concentration. Y is the response
Y is ∆RFU and starts at Bottom and goes to Top with a sigmoid shape.

Figure 2. Dose dependent stimulation of intracellular IP-One accumulation upon treatment with 26RFa in CHO-K1/GPR103/Gα15 cells. d2 acceptor fluorophore-labeled IP-One (Cat. No. 62IPAPEB; Revvity) and intracellular IP-One in CHO-K1/GPR103/Gα15 cells competitively bind with Europium Cryptate-labeled anti-IP-One antibody. The FRET signal decreases as the intracellular IP-One concentration rises and was measured by plate reader (Pherastar, BMG). The EC50 of 26RFa on CHO-K1/GPR103/Gα15 cells was 0.23 μM.
CHO-K1/GPR103/Gα15 Stable Cell Line
M00321 | |
|
|
询价 | |
|
|
|
|
联系黄金城集团 |